Attovia Therapeutics Inc. (ATTO)
NYSE
Closed
Aug 24, 2026
Day's Range
19.7452 wk Range
16.15Overview - ATTO - Attovia Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
224.23M
P/E (Trailing)
‪-8.74‬
P/E (Forward)
‪-0.19‬
Price / Sales (TTM)
‪657.22‬
Price / Book
‪-4.23‬
EV / EBITDA
‪-3.19‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-5,260.00%‬
Return on Assets
‪-36.70%‬
Return on Equity
‪56.68%‬
Ownership
Shares Outstanding
43.02M
Float
2.47M
Held by Insiders
‪23.69%‬
Held by Institutions
‪47.61%‬
Price stats
50-Day Avg
‪20.55‬
200-Day Avg
‪20.55‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
6 analysts
Market Cap - ATTO - Attovia Therapeutics Inc.
Peers - ATTO - Attovia Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on NYSE.
- ATTONYSEAttovia Therapeutics Inc.895.00MMarket Cap-5.29%52-week change-8.78P/E (Trailing)‪0.00%‬Profit Margin
- BIONYSEBio-Rad Laboratories Inc.10.16BMarket Cap+21.75%52-week change46.50P/E (Trailing)‪8.58%‬Profit Margin
- BHVNNYSEBiohaven Ltd.2.09BMarket Cap-7.87%52-week change-2.02P/E (Trailing)‪0.00%‬Profit Margin
- BSTNYSEBlackRock Science and Technology Trust1.72BMarket Cap+20.82%52-week change6.90P/E (Trailing)‪0.00%‬Profit Margin
- ANRONYSEAlto Neuroscience Inc.1.34BMarket Cap+88.51%52-week change-15.62P/E (Trailing)‪0.00%‬Profit Margin
- BCXNYSEBlackRock Resources & Commodities Strategy Trust1.00BMarket Cap+25.06%52-week change4.60P/E (Trailing)‪0.00%‬Profit Margin
- ARMPNYSEArmata Pharmaceuticals Inc.189.62MMarket Cap+49.02%52-week change-1.05P/E (Trailing)‪0.00%‬Profit Margin
Profile Summary - ATTO - Attovia Therapeutics Inc.
About
Attovia Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing next-generation therapies for immune-mediated diseases. Its work centers on the ATTOBODY biologics platform, which is used to design precision medicines aimed at inflammatory and immune-driven conditions. The company’s…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
